Cybersicurezza per i dispositivi medici (MDR/IVDR)
I dispositivi medici connessi e il software come dispositivo medico devono essere sviluppati in modo sicuro, documentati e monitorati sul campo ai sensi di MDR e IVDR. Complass accompagna fabbricanti e fornitori della tecnologia medica dal modello delle minacce alla segnalazione delle vulnerabilità.
Compliance management in 20 secondiProgetto, prossimo passo, checklist, dichiarazione di applicabilità, pacchetto per l’audit. Beispieldaten der Demo-Firma.
Che cos’è Dispositivi medici?
Il Regolamento sui dispositivi medici (UE) 2017/745 (MDR) e il Regolamento sui dispositivi medico-diagnostici in vitro (UE) 2017/746 (IVDR) richiedono che il software sia sviluppato secondo lo stato dell’arte, che la gestione dei rischi comprenda la sicurezza delle informazioni e che i fabbricanti definiscano requisiti minimi per hardware, reti IT e misure di sicurezza IT. La linea guida MDCG 2019-16 Rev. 1 chiarisce che cosa ciò significhi in pratica.
Aggiornamento dei contenuti:
Vale anche per me?
I requisiti si applicano ai fabbricanti di dispositivi medici e di dispositivi diagnostici in vitro che contengono software o sono essi stessi software. I fornitori di elettronica, software embedded, moduli radio o produzione per conto terzi sono interessati indirettamente: i fabbricanti trasmettono loro i requisiti tramite il sistema di gestione della qualità e i contratti e si aspettano, ad esempio, SBOM, scheda tecnica di sicurezza e impegni sugli aggiornamenti.
I dispositivi medici sono esclusi dal Cyber Resilience Act. I componenti con elementi digitali venduti anche autonomamente o al di fuori della tecnologia medica rientrano invece, di regola, nel CRA. I fabbricanti di dispositivi medici e di dispositivi diagnostici in vitro possono rientrare inoltre nella NIS2 a partire da una dimensione aziendale media (allegato 2 BSIG).
Questa panoramica non sostituisce la consulenza legale. Fa fede il testo giuridico o normativo; in Complass verificate l’applicabilità con indicazioni basate sui riferimenti.
Base giuridica
Art. 2 MDRArticle 2 MDRDefinitionsFor the purposes of this Regulation, the following definitions apply: (1) ‘medical device’ means any instrument, apparatus, appliance, software, implant, reagent, material or other article intended by the manufacturer to be used, alone or in combination, for human beings for one or more of the following specific medical purposes: - diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗Definizioni, tra cui dispositivo medico e accessorio
Art. 10 MDRArticle 10 MDRGeneral obligations of manufacturers1. When placing their devices on the market or putting them into service, manufacturers shall ensure that they have been designed and manufactured in accordance with the requirements of this Regulation. 2. Manufacturers shall establish, document, implement and maintain a system for risk management as described in Section 3 of Annex I. 3. Manufacturers shall conduct a clinical evaluation in accordance with the …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗Obblighi generali dei fabbricanti
Anhang I Abschn. 17.2 MDRAnnex I Section 17.2 MDRFor devices that incorporate software or for software that are devices in themselves, the software shall be developed and manufactured in accordance with the state of the art taking into account the principles of development life cycle, risk management, including information security, verification and validation.Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗Ciclo di vita del software, gestione dei rischi comprensiva della sicurezza delle informazioni
Anhang I Abschn. 17.4 MDRAnnex I Section 17.4 MDRManufacturers shall set out minimum requirements concerning hardware, IT networks characteristics and IT security measures, including protection against unauthorised access, necessary to run the software as intended.Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗Requisiti minimi per hardware, reti IT e misure di sicurezza IT
Art. 83 MDRArticle 83 MDRPost-market surveillance system of the manufacturer1. For each device, manufacturers shall plan, establish, document, implement, maintain and update a post-market surveillance system in a manner that is proportionate to the risk class and appropriate for the type of device. That system shall be an integral part of the manufacturer's quality management system referred to in Article 10(9). 2. The post-market surveillance system shall be suited to actively and …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗Sistema di sorveglianza post-commercializzazione
Art. 87 MDRArticle 87 MDRReporting of serious incidents and field safety corrective actions1. Manufacturers of devices made available on the Union market, other than investigational devices, shall report, to the relevant competent authorities, in accordance with Articles 92(5) and (7), the following: - (a) any serious incident involving devices made available on the Union market, except expected side-effects which are clearly documented in the product information and quantified in the technical …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗Segnalazione di incidenti gravi e di azioni correttive di sicurezza sul campo
Anhang I Abschn. 16.2 IVDRAnnex I Section 16.2 IVDRFor devices that incorporate software or for software that are devices in themselves, the software shall be developed and manufactured in accordance with the state of the art taking into account the principles of development life cycle, risk management, including information security, verification and validation.Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Apri l’originale (EUR-Lex – consolidated version of 10.01.2025) ↗Requisito corrispondente per il software dei dispositivi diagnostici in vitro
Art. 2 Abs. 2 CRAArticolo 2 Regolamento sulla ciberresilienzaAmbito di applicazione1. Il presente regolamento si applica ai prodotti con elementi digitali messi a disposizione sul mercato la cui finalità prevista o il cui utilizzo ragionevolmente prevedibile include una connessione dati logica o fisica diretta o indiretta a un dispositivo o a una rete. 2. Il presente regolamento non si applica ai prodotti con elementi digitali a cui si applicano i seguenti atti giuridici dell’Unione: - a) …Stato: 06.10.2026 · Fonte: EUR-Lex – OJ L 2024/2847, 20.11.2024, corrigenda incorporated: OJ L 2025/90555, 2.7.2025; OJ L 2025/90828, 17.10.2025Apri l’originale (EUR-Lex – OJ L 2024/2847, 20.11.2024, corrigenda incorporated: OJ L 2025/90555, 2.7.2025; OJ L 2025/90828, 17.10.2025) ↗Esclusione dei dispositivi medici dal Cyber Resilience Act
Date chiave
Date of application of the MDR · Art. 123(2) MDRArticle 123 MDREntry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2021 . 3. By way of derogation from paragraph 2: - (a) Articles 35 to 50 shall apply from 26 November 2017. However, from that date until 26 May 2021 , the obligations on notified bodies pursuant to Articles 35 to 50 shall apply only to those …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗
Date of application of the IVDR · Art. 113(2) IVDRArticle 113 IVDREntry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2022. 3. By way of derogation from paragraph 2: ————— - (b) Articles 31 to 46 and Article 96 shall apply from 26 November 2017. However, from that date until 26 May 2022 the obligations on notified bodies pursuant to Articles 31 to 46 shall …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Apri l’originale (EUR-Lex – consolidated version of 10.01.2025) ↗
MDR legacy devices: QMS in accordance with Art. 10(9) put in place and formal application lodged with a notified body (condition of the transitional period) · Art. 120(3c)(d) and (e) MDRArticle 120 MDRTransitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗
MDR legacy devices: written agreement signed with the notified body (condition of the transitional period) · Art. 120(3c)(e) MDRArticle 120 MDRTransitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗
Obligations relating to the first Eudamed modules (actors, UDI/devices, notified bodies and certificates, market surveillance) apply · Art. 123(3)(d) MDR in conjunction with Decision (EU) 2025/2371Article 123 MDREntry into force and date of application1. This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union. 2. It shall apply from 26 May 2021 . 3. By way of derogation from paragraph 2: - (a) Articles 35 to 50 shall apply from 26 November 2017. However, from that date until 26 May 2021 , the obligations on notified bodies pursuant to Articles 35 to 50 shall apply only to those …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗
IVDR legacy devices of class B and sterile class A: formal application lodged with a notified body no later than · Art. 110(3c)(e)(iii) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Apri l’originale (EUR-Lex – consolidated version of 10.01.2025) ↗
IVDR legacy devices of class B and sterile class A: written agreement with the notified body no later than · Art. 110(3c)(f)(iii) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Apri l’originale (EUR-Lex – consolidated version of 10.01.2025) ↗
End of the MDR transitional period for class III and class IIb implantable devices (with exceptions), under the conditions of Art. 120(3c) · Art. 120(3a)(a) MDRArticle 120 MDRTransitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗
End of the IVDR transitional period for devices with a certificate under Directive 98/79/EC and for class D, under the conditions of Art. 110(3c) · Art. 110(3a), (3b)(a) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Apri l’originale (EUR-Lex – consolidated version of 10.01.2025) ↗
End of the MDR transitional period for other class IIb, class IIa, class I sterile or with a measuring function, and for devices that require a notified body only under the MDR · Art. 120(3a)(b), (3b) MDRArticle 120 MDRTransitional provisions1. From 26 May 2021 , any publication of a notification in respect of a notified body in accordance with Directives 90/385/EEC and 93/42/EEC shall become void. 2. Certificates issued by notified bodies in accordance with Directives 90/385/EEC and 93/42/EEC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex 4 to …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 19.07.2026Apri l’originale (EUR-Lex – consolidated version of 19.07.2026) ↗
End of the IVDR transitional period for class C · Art. 110(3b)(b) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Apri l’originale (EUR-Lex – consolidated version of 10.01.2025) ↗
End of the IVDR transitional period for class B and sterile class A · Art. 110(3b)(c) IVDRArticle 110 IVDRTransitional provisions1. From 26 May 2022, any publication of a notification in respect of a notified body in accordance with Directive 98/79/EC shall become void. 2. Certificates issued by notified bodies in accordance with Directive 98/79/EC prior to 25 May 2017 shall remain valid until the end of the period indicated on the certificate, except for certificates issued in accordance with Annex VI to Directive 98/79/EC which shall become …Stato: 05.10.2026 · Fonte: EUR-Lex – consolidated version of 10.01.2025Apri l’originale (EUR-Lex – consolidated version of 10.01.2025) ↗
Data di applicazione e periodi transitori secondo le versioni consolidate di MDR e IVDR. Una proposta della Commissione del 16.12.2025 (COM(2025) 1023) prevede ulteriori obblighi di notifica per le vulnerabilità; non è ancora stata adottata.
Come Complass aiuta
Sette fasi lungo il ciclo di vita
Classificazione e ruolo, sviluppo sicuro con gestione dei rischi, requisiti minimi per l’ambiente IT, documentazione tecnica, sorveglianza post-commercializzazione e vigilanza, nonché una fase dedicata ai fornitori.
Cataloghi dei requisiti
Requisiti cyber da MDR e IVDR, misure secondo MDCG 2019-16 e attività di sicurezza nel ciclo di vita con stato ed evidenza, collegabili a CRA, IEC 62443 e ISO 27001.
Modelli
tra l’altro piano di sicurezza, modello delle minacce, fascicolo di gestione dei rischi di sicurezza, elenco SBOM, requisiti minimi per l’ambiente IT, politica di divulgazione coordinata, concetto di patch e aggiornamento e accordo di sicurezza con i fornitori.
Vulnerabilità e incidenti
Confronto della SBOM con le vulnerabilità note, registrazione degli incidenti e panoramica dei termini di notifica.
Le fasi nel modulo
Qualification, role and demarcation
Secure development across the lifecycle
Minimum requirements for the IT environment and operator information
Technical documentation and conformity assessment
After placing on the market: surveillance, vulnerabilities, updates and vigilance
Suppliers to the medical technology industry
Implementation in Complass
Catalogo: MDR/IVDR requirements relevant to cybersecurity
Il modello settoriale “Tecnologia medica” preseleziona il framework per MDR e IVDR e i moduli che servono per il modello delle minacce, le vulnerabilità e i fornitori.
disponibile
Modello settoriale: Tecnologia medica
Cybersicurezza per i dispositivi medici secondo MDR e IVDR
Vulnerabilità e SBOM
Risk management
MITRE ATT&CK per il modello delle minacce
Supplier Management
da 476 € al mese più IVA nel pacchetto Start, dimensione S, pagamento annuale
Tutti i prezzi si rivolgono alle imprese, non ai consumatori. Si intendono al netto più IVA con pagamento annuale; per il pagamento mensile si applica una maggiorazione del 15 %. Aggiornato al 16/10/2026. Enterprise e gruppi di imprese su richiesta.
Domande frequenti
Forniamo solo elettronica e firmware ai fabbricanti di tecnologia medica. Ci riguarda?+
Indirettamente sì: i Suoi clienti devono dimostrare i requisiti cyber della MDR e si aspettano da Lei informazioni e impegni a tal fine. Se vende il componente anche ad altri settori, di regola si applica inoltre il Cyber Resilience Act. Il modulo contiene una fase dedicata ai fornitori.
Il modulo sostituisce il nostro sistema di gestione della qualità?+
No. Complass struttura i requisiti cyber e le evidenze e si integra nel Suo SGQ esistente; valutazione della conformità e approvazioni restano a Lei e al Suo organismo notificato.
Sono incluse norme come la IEC 81001-5-1?+
Il modulo descrive le attività con parole proprie, con rimando alle sezioni. Il testo della norma deve essere acquistato presso i rivenditori di norme; estratti della Sua edizione con licenza possono essere archiviati nel progetto.
Provate Complass con i vostri dati
Create voi stessi il vostro accesso di prova, se volete con un progetto di esempio per ogni quadro normativo. Se preferite vedere prima Complass, richiedete una demo.